NCT04460768View on ClinicalTrials.gov

An INternational Frontline Ovarian Cancer Real World Management Study

CompletedOBSERVATIONAL
Enrollment

989

Participants

Timeline

Start Date

June 27, 2020

Primary Completion Date

November 10, 2020

Study Completion Date

November 10, 2020

Conditions
Ovarian Neoplasms
Trial Locations (4)

D0817R00028

Research Site, Melbourne

Research Site, Seoul

Research Site, New Taipei City

Research Site, Taipei

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY